Scott Kahn, based in New York, NY, US, is currently a Founder at Alykomed Global Solutions LLC, bringing experience from previous roles at International Cancer Advocacy Network (ICAN), W GLOBAL CAPITAL LIMITED, Intercept Pharmaceuticals and Oncostem Biotherapeutics, LLC.. Scott Kahn holds a 1988 - 1994 Postdoctorate in Cancer, Oncology, Cell Biology @ Columbia University in the City of New York. With a robust skill set that includes Cancer Research, Symposium Organizer, High Throughput Screening, Technology, qPCR and more, Scott Kahn contributes valuable insights to the industry. Scott Kahn has 2 emails on RocketReach.